Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Rufy2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of RUFY2 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUFY2 mRNA | CTD | PMID:17942748 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUFY2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rufy2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RUFY2 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of RUFY2 mRNA | CTD | PMID:30851411 | acrolein | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY2 mRNA | CTD | PMID:32699268 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of RUFY2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | RUFY2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of RUFY2 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RUFY2 mRNA | CTD | PMID:23724009 | alpha-pinene | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY2 mRNA | CTD | PMID:32699268 | antirheumatic drug | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of RUFY2 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RUFY2 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | RUFY2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RUFY2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RUFY2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RUFY2 gene | CTD | PMID:25304211 | benzo[a]pyrene | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA | CTD | PMID:27858113 | benzo[b]fluoranthene | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RUFY2 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | affects methylation | ISO | RUFY2 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of RUFY2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Rufy2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RUFY2 mRNA | CTD | PMID:33221593 | butanal | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of RUFY2 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUFY2 mRNA | CTD | PMID:35301059 | cadmium dichloride | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of RUFY2 mRNA | CTD | PMID:26472689 | cadmium dichloride | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUFY2 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | ISO | Rufy2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene | CTD | PMID:20938992 | chrysene | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA | CTD | PMID:27858113 | dorsomorphin | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RUFY2 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Rufy2 (Mus musculus) | 6480464 | Ethanol affects the splicing of RUFY2 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of RUFY2 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of RUFY2 mRNA | CTD | PMID:20655997 and PMID:23649840 | geldanamycin | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of RUFY2 mRNA | CTD | PMID:26705709 | L-methionine | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene | CTD | PMID:20938992 | leflunomide | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of RUFY2 mRNA | CTD | PMID:28988120 | methotrexate | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of RUFY2 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of RUFY2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of RUFY2 mRNA | CTD | PMID:23179753 and PMID:27188386 | methylmercury chloride | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of RUFY2 mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA more ... | CTD | PMID:32699268 | paracetamol | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of RUFY2 mRNA | CTD | PMID:21420995 | PCB138 | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenylmercury acetate | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of RUFY2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | rac-lactic acid | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of RUFY2 mRNA | CTD | PMID:30851411 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of RUFY2 mRNA | CTD | PMID:27900601 | SB 431542 | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of RUFY2 mRNA | CTD | PMID:19281266 | tetraphene | multiple interactions | ISO | Rufy2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA | CTD | PMID:27858113 | thimerosal | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of RUFY2 mRNA | CTD | PMID:27188386 | trichostatin A | increases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of RUFY2 mRNA | CTD | PMID:24935251 | trichostatin A | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of RUFY2 mRNA | CTD | PMID:24935251 | triptonide | decreases expression | ISO | Rufy2 (Mus musculus) | 6480464 | triptonide results in decreased expression of RUFY2 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of RUFY2 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RUFY2 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RUFY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA | CTD | PMID:27188386 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RUFY2 mRNA | CTD | PMID:19015723 | vitamin E | decreases expression | ISO | RUFY2 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of RUFY2 mRNA | CTD | PMID:19244175 | |